CIO
SEPTEMBER 18, 2023
It’s a win-win when you can get the long-term vision and growth of a company tied to individual career and professional development,” says Mark Yunger, vice president, head of IT at Servier Pharmaceuticals. From an individual’s perspective, it keeps careers interesting and helps people grow with the organization.
ArchIntel
JANUARY 26, 2021
The Greater Boston Area-based senior manager’s primary responsibilities include monitoring competitor and customer activities, direct threat assessments , and ensuring that the biotech company is in an optimal competitive position in terms of its product releases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
ArchIntel
MARCH 9, 2021
“The global pharmaceuticals market size is expected to gain momentum by reaching USD 2,151.1 The BI and analytics director will also carry out qualitative and quantitative market research and analytics initiatives to support existing and future assets. ArchIntel™ -. billion by 2027 while exhibiting a CAGR of 7.0%
Fuld
NOVEMBER 1, 2022
BOSTON – Nov 1, 2022 – Fuld & Company, a fast-growing research, analytics, and advisory business, today announced the appointment of Brad Thompson to the role of Advisory Board Member. During his tenure at top pharmaceutical firms such as Pfizer and Merck, Brad was an integral part of the commercial introduction of blockbuster brands.
Sedulo
MARCH 15, 2023
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.
BIS Research
MARCH 19, 2019
This approach enables providers to gather data about the molecular mechanisms of an individual being tested, which further enables researchers to develop targeted therapies and preventive strategies. The precision therapeutics is segmented into clinical trials, cell therapy, drug discovery and research, and gene therapy.
Alpha Sense BI
MAY 28, 2024
The top three trending sectors—information technology, healthcare/biotech, and business and financial services— ushered in funding rounds over $100 million since the beginning of the year. Want to learn about how AlphaSense is empowering venture capital firms to accelerate their research efforts?
Expert insights. Personalized for you.
849 
Let's personalize your content